pharmacogenomics
December 23, 2019
Meet Eric Matey, Pharm.D., R.Ph.: moving drug-gene testing into clinical care
By Sharon Rosen 
If you’ve picked up a prescription from your local pharmacy, you may have spoken with a pharmacist about how and when to take a medication or its potential side effects. At Mayo Clinic, pharmacists perform these same tasks, but their role extends much further by helping move genomics discoveries into clinical care. “Our pharmacy team […]
Tags: #drug-gene interactions, #RIGHT 10K study, center for individualized medicine, Center for Individualized Medicine Pharmacogenomics Program, Eric Matey, Genetic Testing, genomics, individualized medicine, mayo clinic, pharmacy
July 23, 2019
From ancestry to health traits – how do I know if genetic testing may be right for me?
By Sharon Rosen
Article by Shannon Wieloch Last month we posted a blog on helpful tips to know before taking a DNA test. In part II of this topic, we delve deeper into the types of genetic testing commonly available to help you decide what type of testing may be right for you. Some genetic tests inform you […]
Tags: #disease risk, #drug-gene reactions, #Genetic diseases, #hereditary diseases, ancestry, at home DNA tests, carrier screening, center for individualized medicine, direct-to-consumer genetic tests, dna test, Genetic Counseling, Genetic Counselor
July 16, 2019
Kentucky community hospital develops precision medicine program with help from Mayo Clinic
By Sharon Rosen
Article by Rachel Guibert and Alyson Gonzalez When staff at St. Elizabeth Healthcare in Kentucky — a Mayo Clinic Care Network member — decided that they wanted to bring precision medicine to their patients, they turned to Mayo Clinic for help. “We’re a community hospital that doesn’t have the deep resources academically, and in order […]
Tags: ActX, center for individualized medicine, Dr. Eric Matey, Dr. Mark Larson, genetic screening service, Genetic Testing, health care consulting, mayo clinic, Mayo Clinic Care Network, Mayo Clinic Individualizing Medicine Conference, St. Elizabeth Heathcare
June 17, 2019
Considering a DNA test? Helpful tips before you take the plunge
By Sharon Rosen
Article by Shannon Wieloch The availability of genetic testing has exploded. You hear about it on television, the radio and the internet. Family members are verifying age-old stories of their ancestry. Co-workers are talking about the genes that predispose them to weigh 12% less than average. With everyone doing it, a consumer may think, “Well, […]
Tags: #direct-to-consumer genetic testing, #disease risk, #drug-gene interactions, carrier screening, center for individualized medicine, data privacy, diagnostic tests, Genetic Testing, mayo clinic, Mayo Clinic GeneGuide
June 10, 2019
Meet William Bobo, M.D. – taking the guesswork out of finding the right depression therapy
By Sharon Rosen
Depression can touch every aspect of a person’s life – affecting the way they think, feel and behave. It is also the leading medical condition for those who complete suicide. Getting the right therapy is crucial. But for patients suffering from the disorder, finding an effective treatment often involves trial and error. That’s because it […]
Tags: #Artificial Intelligence, #Center for Individualized Mediicine, #Dr. Arjun Athreya, #Dr. William Bobo, #individualized mediicne, #Mayo Clinic and Illinois Alliance for Technology-Based Healthcare, #mood disorders, #predictive algorithm, #selective serotonin reuptake inhibitors, #targeted therapies, #Treatment response, antidepressants
May 29, 2019
By Sharon Rosen
Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma
April 23, 2019
Editorial: Why DNA sequencing is an effective tool for patient care
By Keith Stewart, M.B., CH.B. For the past 30 years, I’ve been fortunate enough to work with and help many patients. But over that time, I’ve also met people who did not respond to therapy or had significant side effects, while others had marvelous responses. Cases like these show a clear need for personalized medicine. […]
Tags: #rare and undiagnosed diseases, DNA Sequencing, Dr. Keith Stewart, Mayo Clinic Center for Individualized Medicine, pharmacogenomics, undiagnosed disease
December 10, 2018
RIGHT 10K: Blazing a trail to health care’s future
Mayo Clinic’s Center for Individualized Medicine (CIM) is nearing the finish line of the first stage of its unique RIGHT 10K study—an effort that doesn’t involve running shoes but nevertheless is paving the way to prescribing medications matched to a person’s genetic code. RIGHT 10K is a clinical research project to genetically sequence more than10,000 […]
Tags: #Dr. Jessica Wright, #Pharmcogenomics, #RIGHT 10K study, Dr. Eric Matey, Mayo Clinic Center for Individualized Medicine, Precision Medicine
November 12, 2018
Novel data-driven approach for precision medicine
Thousands of patients’ tumors have been sequenced in the past decade, yielding a rich source of data on the changes associated with the cancer development and treatment response. However, there are no validated methods that are used in the clinic to select the best therapy. Today, Mayo Clinic researchers report an omics-guided (comprehensive) drug prioritization […]
Tags: #Dr. Krishna Kalari, Dr. Judy Boughey, Dr. Liewei Wang, Dr. Matthew Goetz, Mayo Clinic Center for Individualized Medicine, personal genomics, pharmacogenomics
November 5, 2018
Pharmacogenomics: finding the right drug, dose for cancer therapy
By Sharon Rosen
Each year, nearly 300,000 patients receive the lifesaving chemotherapy 5-fluorouracil (5-FU) to treat many types of cancer, including colorectal, breast, bowel, skin, pancreatic, and esophageal cancer. While it can be an effective treatment, it doesn’t work for everyone. In fact, up to 30 percent of those who receive the standard dose can have serious, life-threatening […]
Tags: #5-fluorouracil, #5-FU chemotherapy, #chemotherapy side effects, #DPYD gene, #drug-gene interactions, #gene verifier model, breast cancer, chemotherapy, colorectal cancer, mayo clinic, Mayo Clinic Cancer Center, Mayo Clinic Center for Individualized Medicine